Results 21 to 30 of about 233,700 (287)
The effect of metformin on biomarkers associated with breast cancer outcomes: a systematic review, meta-analysis, and dose–response of randomized clinical trials [PDF]
, 2020 Purpose: Breast cancer is a leading cause of cancer mortality in developed countries. We performed a meta-analysis of randomized clinical trials to investigate the effect of metformin on biomarkers associated with breast cancer outcomes and to explore ...
Chhabra, M. +9 more
core +2 more sources
A cytohistological study of Ki-67 expression in ovarian tumors
Indian Journal of Pathology and Microbiology, 2011 Background and Objective: The study was conducted to evaluate the diagnostic accuracy of imprint cytology in ovarian neoplasms, and to investigate the biological significance of Ki-67 antigen expression in benign and malignant ovarian tumors and ...
Monisha Choudhury +2 more
doaj +1 more source
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis [PDF]
, 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Bhumsuk Keam +13 more
core +2 more sources
Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy [PDF]
, 2017 BACKGROUND: Studies have partly demonstrated the clinical validity of Ki-67 as a predictive marker in the neoadjuvant setting, but the question of the best cut-off points as well as the importance of this marker as a prognostic factor in partial ...
Kulka, Janina +11 more
core +2 more sources
Expression of ki-67 and p53 in meningiomas
Neoplasma, 2013 Meningiomas account for about 30% of all primary brain tumors. It is difficult to predict the behaviour of meningiomas, and identification of protein markers responsible for the regulation of cell proliferation can be very helpful. The aim of this study was to evaluate immunohistochemical expression of Ki-67 and p53 in 170 meningiomas.A total number of
Pogorelić, Zenon +6 more
openaire +5 more sources
Journal of Translational Medicine, 2023 Background and purpose Ki-67 labeling index (LI) is an important indicator of tumor cell proliferation in glioma, which can only be obtained by postoperative biopsy at present.
Ningfang Du +10 more
doaj +1 more source
Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced stage colorectal cancer [PDF]
, 2017 Current prognostic indicators are ineffective for identifying advanced stage colorectal cancer (CRC) patients with high risk of recurrence after surgical resection. We investigated the prognostic value of p53, Ki-67, and programmed death ligand 1 (PD-L1)
Baldridge, Lee A. +8 more
core +1 more source
Thoracic Cancer, 2019 Background The Ki‐67 labeling index (LI) is a well‐known prognostic factor for primary breast cancer, but its clinical significance for metachronous axillary lymph node (ALN) recurrence has not been well documented.
Naoya Ishibashi +7 more
doaj +1 more source
Effect of inosine pranobex on p16, Ki-67 expression in patients with HPV-associated cervical intraepithelial neoplasia [PDF]
Гинекология, 2018 The aim of the study - to determine the dynamics of expression of р16, Ki-67 in patients with HPV-associated cervical intraepithelial neoplasia (CIN) in the complex treatment with inosine pranobex. Materials and methods.
T V Klinyshkova, O N Mironova
doaj +1 more source
Asian Pacific Journal of Cancer Biology, 2022 Background: CDX2 has been established as a good prognostic marker for colorectal carcinomas. Differentiated adenocarcinomas are characterized by higher CDX2 expression than undifferentiated tumors with stronger reactivity in intestinal phenotypes.
Chatpalli Pranjali +2 more
doaj +1 more source